Hwaseong-si, South Korea

Yong Ho Heo

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • Seongnam-si, KR (2018)
  • Hwaseong-si, KR (2021 - 2023)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Yong Ho Heo: Innovator in Immunostimulating IL-2 Analogs

Introduction

Yong Ho Heo is a prominent inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of immunology, particularly through his work on interleukin-2 (IL-2) analogs. With a total of four patents to his name, Heo's innovations are paving the way for advancements in immunotherapy.

Latest Patents

Yong Ho Heo's latest patents focus on immunostimulating IL-2 analogs. One of his notable inventions involves modifications to interleukin-2 alpha receptors, which are disclosed in his patents. Additionally, he has developed interleukin-2 analogs with increased binding affinity for interleukin-2 beta receptors. These advancements are crucial for enhancing the efficacy of immunotherapies.

Career Highlights

Heo is currently associated with Hanmi Pharm. Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has garnered attention for its potential to improve treatment options for various diseases.

Collaborations

Some of his notable coworkers include Dae Jin Kim and Sung Youb Jung. Their collaborative efforts contribute to the ongoing research and development in immunology.

Conclusion

Yong Ho Heo's contributions to the field of immunology through his patents on IL-2 analogs highlight his role as a key innovator. His work not only advances scientific understanding but also holds promise for future therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…